Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)

(-) Description

Title :  X-RAY STRUCTURE OF A DELETION VARIANT OF HUMAN GLUCOSE 6-PHOSPHATE DEHYDROGENASE COMPLEXED WITH STRUCTURAL AND COENZYME NADP
 
Authors :  S. Gover, L. Vandeputte-Rutten, S. W. N. Au, M. J. Adams
Date :  08 Jan 05  (Deposition) - 25 Apr 05  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.50
Chains :  Asym. Unit :  A
Biol. Unit 1:  A  (2x)
Keywords :  Oxidoreductase, Oxidoreductase (Choh(D)-Nadp), Carbohydrate Metabolism, Glucose Metabolism (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  M. Kotaka, S. Gover, L. Vandeputte-Rutten, S. W. N. Au, V. M. S. Lam, M. J. Adams
Structural Studies Of Glucose-6-Phosphate And Nadp+ Binding To Human Glucose-6-Phosphate Dehydrogenase
Acta Crystallogr. , Sect. D V. 61 495 2005
PubMed-ID: 15858258  |  Reference-DOI: 10.1107/S0907444905002350
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE
    ChainsA
    EC Number1.1.1.49
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System PlasmidPKKG6PD
    Expression System StrainDR612
    Expression System Taxid562
    FragmentRESIDUES 26-514
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymG6PD

 Structural Features

(-) Chains, Units

  1
Asymmetric Unit A
Biological Unit 1 (2x)A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 4)

Asymmetric Unit (2, 4)
No.NameCountTypeFull Name
1GOL2Ligand/IonGLYCEROL
2NAP2Ligand/IonNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE
Biological Unit 1 (2, 8)
No.NameCountTypeFull Name
1GOL4Ligand/IonGLYCEROL
2NAP4Ligand/IonNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE

(-) Sites  (4, 4)

Asymmetric Unit (4, 4)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREGLY A:38 , SER A:40 , GLY A:41 , ASP A:42 , LEU A:43 , ARG A:72 , SER A:73 , GLN A:111 , TYR A:112 , ASP A:114 , ALA A:141 , LEU A:142 , PRO A:143 , TYR A:147 , GLU A:170 , LYS A:171 , HOH A:2154 , HOH A:2155BINDING SITE FOR RESIDUE NAP A 799
2AC2SOFTWARELYS A:238 , LYS A:366 , ARG A:370 , ARG A:393 , TYR A:401 , LYS A:403 , ASP A:421 , THR A:423 , ARG A:487 , ASP A:493 , PHE A:501 , TYR A:503 , TYR A:507 , TRP A:509 , HOH A:2152 , HOH A:2157 , HOH A:2159 , HOH A:2161BINDING SITE FOR RESIDUE NAP A 811
3AC3SOFTWAREGLY A:248 , TYR A:249 , GLU A:252 , THR A:327BINDING SITE FOR RESIDUE GOL A1516
4AC4SOFTWAREPRO A:467 , GLN A:471 , LEU A:474 , HOH A:2162BINDING SITE FOR RESIDUE GOL A1517

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2BH9)

(-) Cis Peptide Bonds  (2, 2)

Asymmetric Unit
No.Residues
1Lys A:171 -Pro A:172
2Gln A:395 -Pro A:396

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (65, 65)

Asymmetric Unit (65, 65)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_002451H32RG6PD_HUMANDisease (NSHA)137852340AH32R
02UniProtVAR_002453A44GG6PD_HUMANDisease (NSHA)78478128AA44G
03UniProtVAR_002454I48TG6PD_HUMANDisease (NSHA)76645461AI48T
04UniProtVAR_002455D58NG6PD_HUMANDisease (NSHA)137852315AD58N
05UniProtVAR_002456V68MG6PD_HUMANDisease (NSHA)1050828AV68M
06UniProtVAR_002457Y70HG6PD_HUMANDisease (NSHA)137852349AY70H
07UniProtVAR_002458L75PG6PD_HUMANDisease (NSHA)  ---AL75P
08UniProtVAR_002460R81CG6PD_HUMANDisease (NSHA)138687036AR81C
09UniProtVAR_002459R81HG6PD_HUMANDisease (NSHA)782308266AR81H
10UniProtVAR_002461S106CG6PD_HUMANDisease (NSHA)267606835AS106C
11UniProtVAR_002462N126DG6PD_HUMANPolymorphism1050829AN126D
12UniProtVAR_002463L128PG6PD_HUMANDisease (NSHA)78365220AL128P
13UniProtVAR_002464G131VG6PD_HUMANPolymorphism137852341AG131V
14UniProtVAR_002465E156KG6PD_HUMANDisease (NSHA)137852313AE156K
15UniProtVAR_002467G163DG6PD_HUMANDisease (NSHA)  ---AG163D
16UniProtVAR_002466G163SG6PD_HUMANDisease (NSHA)137852314AG163S
17UniProtVAR_002468N165DG6PD_HUMANDisease (NSHA)137852331AN165D
18UniProtVAR_002469R166HG6PD_HUMANDisease (NSHA)  ---AR166H
19UniProtVAR_002470D176GG6PD_HUMANDisease (NSHA)  ---AD176G
20UniProtVAR_002471D181VG6PD_HUMANDisease (NSHA)5030872AD181V
21UniProtVAR_002472R182WG6PD_HUMANDisease (NSHA)267606836AR182W
22UniProtVAR_002473S188FG6PD_HUMANDisease (NSHA)5030868AS188F
23UniProtVAR_002474R198CG6PD_HUMANDisease (NSHA)137852330AR198C
24UniProtVAR_002475R198PG6PD_HUMANDisease (NSHA)137852332AR198P
25UniProtVAR_075555R198SG6PD_HUMANDisease (NSHA)  ---AR198S
26UniProtVAR_002476M212VG6PD_HUMANDisease (NSHA)782754619AM212V
27UniProtVAR_002477V213LG6PD_HUMANDisease (NSHA)137852326AV213L
28UniProtVAR_002478F216LG6PD_HUMANDisease (NSHA)137852319AF216L
29UniProtVAR_002480R227LG6PD_HUMANDisease (NSHA)137852328AR227L
30UniProtVAR_002479R227QG6PD_HUMANDisease (NSHA)137852328AR227Q
31UniProtVAR_002482R257GG6PD_HUMANDisease (NSHA)  ---AR257G
32UniProtVAR_002483E274KG6PD_HUMANDisease (NSHA)  ---AE274K
33UniProtVAR_002484S278FG6PD_HUMANDisease (NSHA)  ---AS278F
34UniProtVAR_002485T279SG6PD_HUMANDisease (NSHA)  ---AT279S
35UniProtVAR_002486D282HG6PD_HUMANDisease (NSHA)137852318AD282H
36UniProtVAR_002487R285HG6PD_HUMANDisease (NSHA)74575103AR285H
37UniProtVAR_002488V291MG6PD_HUMANDisease (NSHA)137852327AV291M
38UniProtVAR_002489E317KG6PD_HUMANDisease (NSHA)137852339AE317K
39UniProtVAR_020535Y322HG6PD_HUMANPolymorphism137852347AY322H
40UniProtVAR_002490L323PG6PD_HUMANDisease (NSHA)76723693AL323P
41UniProtVAR_002491A335TG6PD_HUMANDisease (NSHA)5030869AA335T
42UniProtVAR_002492L342FG6PD_HUMANPolymorphism137852342AL342F
43UniProtVAR_002493P353SG6PD_HUMANDisease (NSHA)137852333AP353S
44UniProtVAR_002494N363KG6PD_HUMANDisease (NSHA)137852329AN363K
45UniProtVAR_002495C385RG6PD_HUMANDisease (NSHA)137852322AC385R
46UniProtVAR_002496K386EG6PD_HUMANDisease (NSHA)137852320AK386E
47UniProtVAR_002498R387CG6PD_HUMANDisease (NSHA)137852334AR387C
48UniProtVAR_002497R387HG6PD_HUMANDisease (NSHA)137852321AR387H
49UniProtVAR_002499R393HG6PD_HUMANDisease (NSHA)137852316AR393H
50UniProtVAR_002500V394LG6PD_HUMANDisease (NSHA)137852335AV394L
51UniProtVAR_002501P396LG6PD_HUMANDisease (NSHA)  ---AP396L
52UniProtVAR_002502E398KG6PD_HUMANDisease (NSHA)137852325AE398K
53UniProtVAR_002503G410CG6PD_HUMANDisease (NSHA)137852323AG410C
54UniProtVAR_002504G410DG6PD_HUMANDisease (NSHA)137852336AG410D
55UniProtVAR_002505E416KG6PD_HUMANDisease (NSHA)  ---AE416K
56UniProtVAR_002506R439PG6PD_HUMANDisease (NSHA)137852337AR439P
57UniProtVAR_002507L440FG6PD_HUMANDisease (NSHA)  ---AL440F
58UniProtVAR_002508G447RG6PD_HUMANDisease (NSHA)137852317AG447R
59UniProtVAR_002509Q449HG6PD_HUMANDisease (NSHA)  ---AQ449H
60UniProtVAR_002510R454CG6PD_HUMANDisease (NSHA)398123546AR454C
61UniProtVAR_002511R454HG6PD_HUMANDisease (NSHA)137852324AR454H
62UniProtVAR_002512R459LG6PD_HUMANDisease (NSHA)72554665AR459L
63UniProtVAR_002513R459PG6PD_HUMANDisease (NSHA)72554665AR459P
64UniProtVAR_002514R463HG6PD_HUMANDisease (NSHA)72554664AR463H
65UniProtVAR_002515G488VG6PD_HUMANDisease (NSHA)  ---AG488V

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (65, 130)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_002451H32RG6PD_HUMANDisease (NSHA)137852340AH32R
02UniProtVAR_002453A44GG6PD_HUMANDisease (NSHA)78478128AA44G
03UniProtVAR_002454I48TG6PD_HUMANDisease (NSHA)76645461AI48T
04UniProtVAR_002455D58NG6PD_HUMANDisease (NSHA)137852315AD58N
05UniProtVAR_002456V68MG6PD_HUMANDisease (NSHA)1050828AV68M
06UniProtVAR_002457Y70HG6PD_HUMANDisease (NSHA)137852349AY70H
07UniProtVAR_002458L75PG6PD_HUMANDisease (NSHA)  ---AL75P
08UniProtVAR_002460R81CG6PD_HUMANDisease (NSHA)138687036AR81C
09UniProtVAR_002459R81HG6PD_HUMANDisease (NSHA)782308266AR81H
10UniProtVAR_002461S106CG6PD_HUMANDisease (NSHA)267606835AS106C
11UniProtVAR_002462N126DG6PD_HUMANPolymorphism1050829AN126D
12UniProtVAR_002463L128PG6PD_HUMANDisease (NSHA)78365220AL128P
13UniProtVAR_002464G131VG6PD_HUMANPolymorphism137852341AG131V
14UniProtVAR_002465E156KG6PD_HUMANDisease (NSHA)137852313AE156K
15UniProtVAR_002467G163DG6PD_HUMANDisease (NSHA)  ---AG163D
16UniProtVAR_002466G163SG6PD_HUMANDisease (NSHA)137852314AG163S
17UniProtVAR_002468N165DG6PD_HUMANDisease (NSHA)137852331AN165D
18UniProtVAR_002469R166HG6PD_HUMANDisease (NSHA)  ---AR166H
19UniProtVAR_002470D176GG6PD_HUMANDisease (NSHA)  ---AD176G
20UniProtVAR_002471D181VG6PD_HUMANDisease (NSHA)5030872AD181V
21UniProtVAR_002472R182WG6PD_HUMANDisease (NSHA)267606836AR182W
22UniProtVAR_002473S188FG6PD_HUMANDisease (NSHA)5030868AS188F
23UniProtVAR_002474R198CG6PD_HUMANDisease (NSHA)137852330AR198C
24UniProtVAR_002475R198PG6PD_HUMANDisease (NSHA)137852332AR198P
25UniProtVAR_075555R198SG6PD_HUMANDisease (NSHA)  ---AR198S
26UniProtVAR_002476M212VG6PD_HUMANDisease (NSHA)782754619AM212V
27UniProtVAR_002477V213LG6PD_HUMANDisease (NSHA)137852326AV213L
28UniProtVAR_002478F216LG6PD_HUMANDisease (NSHA)137852319AF216L
29UniProtVAR_002480R227LG6PD_HUMANDisease (NSHA)137852328AR227L
30UniProtVAR_002479R227QG6PD_HUMANDisease (NSHA)137852328AR227Q
31UniProtVAR_002482R257GG6PD_HUMANDisease (NSHA)  ---AR257G
32UniProtVAR_002483E274KG6PD_HUMANDisease (NSHA)  ---AE274K
33UniProtVAR_002484S278FG6PD_HUMANDisease (NSHA)  ---AS278F
34UniProtVAR_002485T279SG6PD_HUMANDisease (NSHA)  ---AT279S
35UniProtVAR_002486D282HG6PD_HUMANDisease (NSHA)137852318AD282H
36UniProtVAR_002487R285HG6PD_HUMANDisease (NSHA)74575103AR285H
37UniProtVAR_002488V291MG6PD_HUMANDisease (NSHA)137852327AV291M
38UniProtVAR_002489E317KG6PD_HUMANDisease (NSHA)137852339AE317K
39UniProtVAR_020535Y322HG6PD_HUMANPolymorphism137852347AY322H
40UniProtVAR_002490L323PG6PD_HUMANDisease (NSHA)76723693AL323P
41UniProtVAR_002491A335TG6PD_HUMANDisease (NSHA)5030869AA335T
42UniProtVAR_002492L342FG6PD_HUMANPolymorphism137852342AL342F
43UniProtVAR_002493P353SG6PD_HUMANDisease (NSHA)137852333AP353S
44UniProtVAR_002494N363KG6PD_HUMANDisease (NSHA)137852329AN363K
45UniProtVAR_002495C385RG6PD_HUMANDisease (NSHA)137852322AC385R
46UniProtVAR_002496K386EG6PD_HUMANDisease (NSHA)137852320AK386E
47UniProtVAR_002498R387CG6PD_HUMANDisease (NSHA)137852334AR387C
48UniProtVAR_002497R387HG6PD_HUMANDisease (NSHA)137852321AR387H
49UniProtVAR_002499R393HG6PD_HUMANDisease (NSHA)137852316AR393H
50UniProtVAR_002500V394LG6PD_HUMANDisease (NSHA)137852335AV394L
51UniProtVAR_002501P396LG6PD_HUMANDisease (NSHA)  ---AP396L
52UniProtVAR_002502E398KG6PD_HUMANDisease (NSHA)137852325AE398K
53UniProtVAR_002503G410CG6PD_HUMANDisease (NSHA)137852323AG410C
54UniProtVAR_002504G410DG6PD_HUMANDisease (NSHA)137852336AG410D
55UniProtVAR_002505E416KG6PD_HUMANDisease (NSHA)  ---AE416K
56UniProtVAR_002506R439PG6PD_HUMANDisease (NSHA)137852337AR439P
57UniProtVAR_002507L440FG6PD_HUMANDisease (NSHA)  ---AL440F
58UniProtVAR_002508G447RG6PD_HUMANDisease (NSHA)137852317AG447R
59UniProtVAR_002509Q449HG6PD_HUMANDisease (NSHA)  ---AQ449H
60UniProtVAR_002510R454CG6PD_HUMANDisease (NSHA)398123546AR454C
61UniProtVAR_002511R454HG6PD_HUMANDisease (NSHA)137852324AR454H
62UniProtVAR_002512R459LG6PD_HUMANDisease (NSHA)72554665AR459L
63UniProtVAR_002513R459PG6PD_HUMANDisease (NSHA)72554665AR459P
64UniProtVAR_002514R463HG6PD_HUMANDisease (NSHA)72554664AR463H
65UniProtVAR_002515G488VG6PD_HUMANDisease (NSHA)  ---AG488V

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 1)

Asymmetric Unit (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1G6P_DEHYDROGENASEPS00069 Glucose-6-phosphate dehydrogenase active site.G6PD_HUMAN200-206  1A:200-206
Biological Unit 1 (1, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1G6P_DEHYDROGENASEPS00069 Glucose-6-phosphate dehydrogenase active site.G6PD_HUMAN200-206  2A:200-206

(-) Exons   (12, 12)

Asymmetric Unit (12, 12)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003935641aENSE00001450454X:153775787-153775683105G6PD_HUMAN-00--
1.3aENST000003935643aENSE00001629012X:153774378-153774251128G6PD_HUMAN1-40401A:27-4014
1.4ENST000003935644ENSE00001050596X:153764393-15376435638G6PD_HUMAN41-53131A:41-5313
1.5aENST000003935645aENSE00001200322X:153764260-153764152109G6PD_HUMAN53-89371A:53-8937
1.6aENST000003935646aENSE00001050603X:153763600-153763383218G6PD_HUMAN90-162731A:90-16273
1.7bENST000003935647bENSE00001050595X:153762711-153762553159G6PD_HUMAN162-215541A:162-21554
1.8cENST000003935648cENSE00001050598X:153762375-153762250126G6PD_HUMAN215-257431A:215-25743
1.9bENST000003935649bENSE00001050601X:153761884-15376179194G6PD_HUMAN257-288321A:257-28832
1.10cENST0000039356410cENSE00001050608X:153761343-153761157187G6PD_HUMAN289-351631A:289-35163
1.10eENST0000039356410eENSE00001050602X:153761017-153760782236G6PD_HUMAN351-429791A:351-42979
1.11ENST0000039356411ENSE00001050597X:153760677-15376060177G6PD_HUMAN430-455261A:430-45526
1.12bENST0000039356412bENSE00001050600X:153760495-15376040393G6PD_HUMAN455-486321A:455-48632
1.12dENST0000039356412dENSE00001515849X:153760305-15376021591G6PD_HUMAN486-515301A:486-51530

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:489
 aligned with G6PD_HUMAN | P11413 from UniProtKB/Swiss-Prot  Length:515

    Alignment length:489
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496       506         
           G6PD_HUMAN    27 HQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL 515
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 2bh9A01 A:27-199,A:433-453 NAD(P)-binding Rossmann-like Domain                                                                                                               2bh9A02 A:200-432,A:454-515 Dihydrodipicolinate Reductase; domain 2                                                                                                                                                                      2bh9A01              2bh9A02 A:200-432,A:454-515                                    CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeee...hhhhhhhhhhhhhhhhhh......eeeeeee....hhhhhhhhhhhhh..hhhhhhhhhhhhhheeeee....hhhhhhhhhhhhhh.......eeeeee.....hhhhhhhhhhhhh......eeeee......hhhhhhhhhhhhh...hhh.eee.hhhhhhhhhhhhhhhhhhhhhhh.......eeeeeeeee.......hhhhhh.hhhhhhh..hhhhhhhhhhhh......hhhhhhhhhhhhhh.....hhh.eeeeeee...........hhhhh...........eeeeeee.........eeeeeee......eeeeeeee...............eeeeeee...eeeeeeeee.......eeeeeeeee...........hhhhhhhhhhhhh......hhhhhhhhhhhhhhhhhhhhhhh...eeee.....hhhhhhhhhhh................ Sec.struct. author
             SAPs(SNPs) (1) -----R-----------G---T---------N---------M-H----P-----C------------------------C-------------------D-P--V------------------------K------D-DH---------G----VW-----F---------C-------------VL--L----------L-----------------------------G----------------K---FS--H--H-----M-------------------------K----HP-----------T------F----------S---------K---------------------REC-----HL-L-K-----------C-----K----------------------PF------R-H----C----L---H------------------------V--------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------------------H---------------------------------------------------------------------------------S----------------------------------P----------------------------Q---------------------------------------------------------------------------------------------------------------------------------------------------------------H----------------------D-------------------------------------------H----P-------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------S----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G6P_DEH--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.3a     Exon 1.4     ------------------------------------Exon 1.6a  PDB: A:90-162 UniProt: 90-162                                 ----------------------------------------------------Exon 1.8c  PDB: A:215-257 UniProt: 215-257 -------------------------------Exon 1.10c  PDB: A:289-351 UniProt: 289-351                    ------------------------------------------------------------------------------Exon 1.11  PDB: A:430-455 ------------------------------Exon 1.12d  PDB: A:486-515     Transcript 1 (1)
           Transcript 1 (2) --------------------------Exon 1.5a  PDB: A:53-89              ------------------------------------------------------------------------Exon 1.7b  PDB: A:162-215 UniProt: 162-215            -----------------------------------------Exon 1.9b  PDB: A:257-288       --------------------------------------------------------------Exon 1.10e  PDB: A:351-429 UniProt: 351-429                                    -------------------------Exon 1.12b  PDB: A:455-486      ----------------------------- Transcript 1 (2)
                 2bh9 A  27 VQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL 515
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496       506         

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 2BH9)

(-) CATH Domains  (2, 2)

Asymmetric Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2BH9)

(-) Gene Ontology  (38, 38)

Asymmetric Unit(hide GO term definitions)
Chain A   (G6PD_HUMAN | P11413)
molecular function
    GO:0050661    NADP binding    Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.
    GO:0030246    carbohydrate binding    Interacting selectively and non-covalently with any carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
    GO:0005536    glucose binding    Interacting selectively and non-covalently with the D- or L-enantiomer of glucose.
    GO:0004345    glucose-6-phosphate dehydrogenase activity    Catalysis of the reaction: D-glucose 6-phosphate + NADP+ = D-glucono-1,5-lactone 6-phosphate + NADPH + H+.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016491    oxidoreductase activity    Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
    GO:0006739    NADP metabolic process    The chemical reactions and pathways involving nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; metabolism may be of either the oxidized form, NADP, or the reduced form, NADPH.
    GO:0006740    NADPH regeneration    A metabolic process that generates a pool of NADPH by the reduction of NADP+.
    GO:0005975    carbohydrate metabolic process    The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
    GO:0034599    cellular response to oxidative stress    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
    GO:0006695    cholesterol biosynthetic process    The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
    GO:0043249    erythrocyte maturation    A developmental process, independent of morphogenetic (shape) change, that is required for an erythrocyte to attain its fully functional state.
    GO:0051156    glucose 6-phosphate metabolic process    The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.
    GO:0006006    glucose metabolic process    The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
    GO:0006749    glutathione metabolic process    The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle.
    GO:0006629    lipid metabolic process    The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
    GO:0010734    negative regulation of protein glutathionylation    Any process that decreases the rate, frequency, or extent of protein glutathionylation. Protein glutathionylation is the protein modification process in which a glutathione molecule is added to a protein amino acid through a disulfide linkage.
    GO:0055114    oxidation-reduction process    A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
    GO:0019322    pentose biosynthetic process    The chemical reactions and pathways resulting in the formation of a pentose, any monosaccharide with a chain of five carbon atoms in the molecule.
    GO:0006098    pentose-phosphate shunt    The glucose-6-phosphate catabolic process in which, coupled to NADPH synthesis, glucose-6-P is oxidized with the formation of carbon dioxide (CO2) and ribulose 5-phosphate; ribulose 5-P then enters a series of reactions interconverting sugar phosphates. The pentose phosphate pathway is a major source of reducing equivalents for biosynthesis reactions and is also important for the conversion of hexoses to pentoses.
    GO:0009051    pentose-phosphate shunt, oxidative branch    The branch of the pentose-phosphate shunt which involves the oxidation of glucose 6-P and produces ribulose 5-P, reduced NADP+ and carbon dioxide (CO2).
    GO:0043523    regulation of neuron apoptotic process    Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
    GO:0045471    response to ethanol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
    GO:0032094    response to food    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
    GO:0014070    response to organic cyclic compound    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
    GO:0046390    ribose phosphate biosynthetic process    The chemical reactions and pathways resulting in the formation of ribose phosphate, any phosphorylated ribose sugar.
    GO:0021762    substantia nigra development    The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).
cellular component
    GO:0005813    centrosome    A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0009898    cytoplasmic side of plasma membrane    The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0043231    intracellular membrane-bounded organelle    Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005815    microtubule organizing center    An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    GOL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAP  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Gln A:395 - Pro A:396   [ RasMol ]  
    Lys A:171 - Pro A:172   [ RasMol ]  
 
Biological Unit
  Complete Structure
    Biological Unit 1  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2bh9
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  G6PD_HUMAN | P11413
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  1.1.1.49
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  300908
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  G6PD_HUMAN | P11413
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        G6PD_HUMAN | P114131qki 2bhl 5ukw

(-) Related Entries Specified in the PDB File

1qki X-RAY STRUCTURE OF HUMAN GLUCOSE 6- PHOSPHATE DEHYDROGENASE (VARIANT CANTON R459L) COMPLEXED WITH STRUCTURAL NADP+